Cocrystal Pharma Inc (COCP)

[mick]

Cocrystal Pharma (COCP) Receives a Buy from H.C. Wainwright
November 29 2021 - 06:17AM
TipRanks
Alert
Print
Share On Facebook
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Cocrystal Pharma (COCP – Research Report) today and set a price target of $4.00. The company's shares closed last Friday at $0.98, close to its 52-week low of $0.79. According to TipRanks.com, Selvaraju is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -11.3% and a 24.3% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as NeuroBo Pharmaceuticals, Oncternal Therapeutics, and Aquestive Therapeutics. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cocrystal Pharma with a $4.50 average price target, which is a 442.
https://www.tipranks.com/news/blurbs/cocrystal-pharma-cocp-receives-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral